Clinical populations with basal ganglia pathologies may present with language production
impairments, which are often described in combination with comprehension measures or …

Dementia is a global growing concern, affecting over 35 million people with a global
economic impact of over $604 billion US. With an ageing population the number of people …

Neurodegenerative diseases are among the leading causes of disability and death
worldwide. The disease-related socioeconomic burden is expected to increase with the …

Alzheimer's disease (AD) is the most common neurodegenerative cause of dementia in the
elderly. AD is accompanied by the accumulation of amyloid peptides in the brain …

Abstract Introduction Both beta‐amyloid (Ab) deposition and decline in white matter integrity,
are brain alterations observed in Alzheimer's disease (AD) and start to occur by the fourth …

Objective Midlife vascular risk factors (MVRFs) are associated with incident dementia, as are
amyloid β (Aβ) deposition and neurodegeneration. Whether vascular and Alzheimer disease …

Objective To evaluate the association between brain amyloid β (Aβ) and cerebral small
vessel disease (CSVD) markers, as well as their joint effect on cognition, in a memory clinic …

Alzheimer's disease (AD) is characterized by the presence of β-amyloid (Aβ) and tau, and
subcortical vascular cognitive impairment (SVCI) is characterized by cerebral small vessel …

Background With the aging population, the prevalence and incidence of cerebrovascular
disease will continue to rise, as well as the number of individuals with vascular cognitive …

Abstract Rationale Biomarker research for Alzheimer's disease (AD) has grown rapidly in
recent years, ensuing the integration of the AD fluid biomarker profile: Aβ1-42, t-tau, and p …